Clinical trial
Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause…
NCT00457561 · Hamamatsu University, Other · Completed
Key facts
| NCT number | NCT00457561 |
|---|---|
| Title | Recombinant Human Erythropoietin Dose, Serum Adiponectin, and All-Cause Mortality in Patients Beginning Hemodialysis |
| Lead sponsor | Hamamatsu University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Hemodialysis |
| First posted | Apr 6, 2007 |
| Last update posted | Apr 6, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: